Accelerate Your Antibody Discovery & Development with ValitaTiter Assays

Request a demo

We are Making Flow Cytometry more Accessible

Discover the Flow Cytometry Learning Center

Straight up, it's better!
Discover a faster path home.

Learn more

Automated Bioreactor Sample Delivery to the Vi-CELL BLU Cell Viability Analyzer

See how it works

Cell Line Development Without Manual Pipetting?


Increase your hits by automating your cell line development

La Diferencia de Beckman Coulter Life Sciences

El compromiso de Beckman Coulter con su investigación se remonta a nuestro origen en 1935. Durante más de 80 años hemos sido un socio de confianza para los profesionales de laboratorio, ayudando a avanzar en la investigación científica y la atención al paciente. Beckman Coulter Life Sciences y es un recurso global en el que confían millones de investigadores de ciencias de la vida, técnicos industriales y medioambientales, y científicos farmacéuticos y biomédicos.

Obtener más información

Últimas noticias y actualizaciones

Press Release

Beckman Coulter Life Sciences Completes First Phase of Colorado Research and Development Hub with Grand Opening of $10 Million Loveland Offices

LOVELAND, CO – (January 19, 2023) – Beckman Coulter Life Sciences, a global leader in laboratory automation and innovation, further strengthens its commitment to the greater Loveland, Colorado community with the completion of the first phase of its new research and development hub.

Más información
Press Release

Beckman Coulter Life Sciences and Pillar Biosciences Sign Application Development Agreement for the Biomek NGeniuS System

INDIANAPOLIS – (October 31, 2022) – More companies around the world continue turning to Beckman Coulter Life Sciences, a global leader in laboratory automation and innovation, for their next generation sequencing (NGS) needs with the Biomek NGeniuS System. The company continues building a robust demonstrated application library as it announces an application development agreement with Pillar Biosciences, which specializes in developing and commercializing IVD & RUO NGS testing solutions that help research to optimize selection of precision therapies for cancer patients, from tumor profiling to therapy selection, and recurrence monitoring.  

Más información
Press Release

Goodbye Manual Gating of Flow Cytometry Data: New Cytobank v10 Platform From Beckman Coulter Life Sciences Provides Powerful Automation Solution

INDIANAPOLIS – (October 18, 2022) – Beckman Coulter Life Sciences, a global leader in laboratory automation and innovation, introduces an automated solution for the grueling and time-consuming process of manual gating flow cytometry data, with no programming skills required. This revolutionary feature is part of the new Cytobank v10 platform upgrade which is available now.

Más información